Document is current

Any future updates will be listed below

Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments

Crossref DOI link: https://doi.org/10.1186/s40345-015-0034-0

Published Online: 2015-09-02

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark